Paid Clinical Trials in New York

New York has 4,879 paid clinical trials enrolling now across cities including New York, The Bronx and Rochester. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in New York include Memorial Sloan Kettering, NYU Langone and Weill Cornell Medicine, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 17, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,284 clinical trials

Get a weekly email when new trials open in New York, NY.

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

for Type 1 Diabetes Mellitus

Sites in New York +5 more locations

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All·Age: 4 - 34

Code: NCT07216391·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

L19IL2/TNF in Patients With Basal Cell Carcinoma

for Locally Advanced Basal Cell Carcinoma

Sites in New York +4 more locations

Sponsor: Philogen S.p.A.

Sex: All·Age: 18+

Code: NCT07227870·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment

for Heart Failure

1 location in New York

Sponsor: Visiting Nurse Service of New York

Sex: All·Age: 18 - 101

Code: NCT07220798·Recruiting·Listed Oct 2025

Apply to this trial

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

for Esophageal Squamous Cell Carcinoma

Sites in New York +9 more locations

Sponsor: Plexium, Inc.

Sex: All·Age: 18+

Code: NCT07284186·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

for Sepsis

Sites in The Bronx +13 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 80

Code: NCT07215702·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis

for FSGS

Sites in New York +1 more location

Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07213960·Phase 2, Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

for Breast Cancer

Sites in New York +4 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07205822·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for Non-alcoholic Fatty Liver Disease

Sites in New York, East Syracuse +50 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 75

Code: NCT07221188·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for Non-alcoholic Fatty Liver Disease

Sites in New York, East Syracuse +74 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 75

Code: NCT07221227·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

for Prostate Cancer

Sites in Commack +4 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT07192614·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

for T-cell NHL (PTCL or CTCL)

Drug: KK2223

Sites in New York +13 more locations

Sponsor: Kyowa Kirin, Inc.

Sex: All·Age: 18+

Code: NCT07192471·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in New York +8 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 130

Code: NCT07181161·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

for Granulomatosis With Polyangiitis

Sites in New York +1 more location

Sponsor: Robert Spiera, MD

Sex: All·Age: 18+

Code: NCT07176546·Phase 2, Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

for Bronchiectasis

Sites in New Hyde Park +30 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 85

Code: NCT07201051·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Caffeine Optimization for Oxygen Saturation Index in ELBW Infants

for Neonatal Apnea

1 location in Rochester

Sponsor: University of Rochester

Sex: All·Age: 0 Days - 27 Weeks

Code: NCT07216365·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for Epithelial Ovarian Cancer

Sites in The Bronx +38 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07218809·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)

for Inflammatory Arthritis

Sites in New York +3 more locations

Sponsor: Smith & Nephew, Inc.

Sex: All·Age: 18 - 80

Code: NCT07199738·Recruiting·Listed Sep 2025

Apply to this trial

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for Pulmonary Hypertension

Sites in New York +10 more locations

Sponsor: Insmed Incorporated

Sex: All·Age: 18+

Code: NCT07179380·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

HemoSphere Alta Study

for Hemodynamic Instability

1 location in Rochester

Sponsor: Becton, Dickinson and Company

Sex: All·Age: 18+

Code: NCT07148323·Recruiting·Listed Aug 2025

Apply to this trial

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for HIV Infections

Sites in Albany, Manhasset +33 more locations

Sponsor: ViiV Healthcare

Sex: All·Age: 18+

Code: NCT07202546·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

for B-cell Non-Hodgkin Lymphoma

Sites in New York +3 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07123454·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

for Bronchiectasis With Pseudomonas Aeruginosa Colonization

Sites in New York +17 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12+

Code: NCT07088926·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

for Chronic Obstructive Pulmonary Disease (COPD)

Sites in Mount Kisco +71 more locations

Sponsor: AstraZeneca

Sex: All·Age: 40+

Code: NCT07082738·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy

for Prostate Carcinoma

1 location in Buffalo

Sponsor: Roswell Park Cancer Institute

Sex: Male·Age: 18+

Code: NCT07075705·Recruiting·Listed Jul 2025

Apply to this trial

Reduction or Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)

for Mitral Regurgitation

Sites in New York +4 more locations

Sponsor: InnovHeart

Sex: All·Age: 18+

Code: NCT07130994·Recruiting·Listed Aug 2025

Apply to this trial

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

for Hypoparathyroidism

Drug: Palopegteriparatide

Sites in New York +6 more locations

Sponsor: Ascendis Pharma Bone Diseases A/S

Sex: All·Age: 18+

Code: NCT07081997·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for Chronic Inflammatory Demyelinating Polyneuropathy

Sites in New York +32 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18+

Code: NCT07032662·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

for Atopic Dermatitis

Sites in New York +22 more locations

Sponsor: Apogee Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07003425·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for Gastroesophageal Adenocarcinoma

Sites in New York +5 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07069712·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

The CHALLENGER Registry

for Chronic Subdural Hematoma

1 location in New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18 - 98

Code: NCT07197840·Recruiting·Listed Sep 2025

Apply to this trial

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for Endometrial Cancer

Drug: Rilvegostomig

Sites in New York +46 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT06989112·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

for Intracranial Meningioma

Sites in New York +15 more locations

Sponsor: RTOG Foundation, Inc.

Sex: All·Age: 18+

Code: NCT06955169·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

for Parkinson Disease

Sites in New York, Albany +17 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 40 - 80

Code: NCT06976268·Phase 2, Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for Graves' Disease

Drug: IMVT-1402

Sites in New York, New Hyde Park +31 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 75

Code: NCT07018323·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

for Lupus Erythematosus, Systemic

Sites in New York, Syracuse +12 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 70

Code: NCT06897930·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

for Parkinson Disease

1 location in Rochester

Sponsor: Radboud University Medical Center

Sex: All·Age: 50+

Code: NCT06993142·Recruiting·Listed May 2025

Apply to this trial

Alleviant ALLAY-HFrEF Study

for Heart Failure

Sites in New York, Rochester +37 more locations

Sponsor: Alleviant Medical, Inc.

Sex: All·Age: 18+

Code: NCT06812533·Recruiting·Listed Feb 2025

Apply to this trial

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

for Ulcerative Colitis (UC)

Sites in Rochester, Albany +28 more locations

Sponsor: Xencor, Inc.

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT06619990·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for Heart Failure

Drug: Dapagliflozin

Sites in New York, Brooklyn +169 more locations

Sponsor: AstraZeneca

Sex: All·Age: 40+

Code: NCT06677060·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

for Lymphoma

Sites in New York +6 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12+

Code: NCT06137144·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial